Г А Франк

660 total citations
80 papers, 435 citations indexed

About

Г А Франк is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Г А Франк has authored 80 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 22 papers in Surgery. Recurrent topics in Г А Франк's work include Breast Cancer Treatment Studies (11 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Prostate Cancer Treatment and Research (8 papers). Г А Франк is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Prostate Cancer Treatment and Research (8 papers). Г А Франк collaborates with scholars based in Russia, Canada and United Kingdom. Г А Франк's co-authors include W.R. Eric Jamieson, A. Ian Munro, Eva Germann, Robert T. Miyagishima, Hilton Ling, Yu Yu Andreeva, Lawrence H. Burr, Л Э Завалишина, A Allegranza and S. Pileri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and Cancer Letters.

In The Last Decade

Г А Франк

65 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Г А Франк Russia 11 200 177 168 91 54 80 435
Lucio Agozzino Italy 15 294 1.5× 279 1.6× 148 0.9× 161 1.8× 38 0.7× 50 576
Nicola Corcione Italy 11 231 1.2× 125 0.7× 144 0.9× 75 0.8× 18 0.3× 59 451
Janine M. Wilkinson United Kingdom 10 99 0.5× 165 0.9× 182 1.1× 313 3.4× 33 0.6× 13 664
Tam N.M. Ngo United States 13 277 1.4× 75 0.4× 95 0.6× 92 1.0× 27 0.5× 30 474
Monique M.H. Marijianowski Netherlands 11 331 1.7× 189 1.1× 65 0.4× 77 0.8× 23 0.4× 17 567
Robert Banyś Poland 13 242 1.2× 185 1.0× 92 0.5× 204 2.2× 12 0.2× 44 541
Nobuhiro Handa Japan 13 365 1.8× 300 1.7× 65 0.4× 141 1.5× 39 0.7× 39 743
Tomotaka Nakayama Japan 14 229 1.1× 109 0.6× 138 0.8× 407 4.5× 22 0.4× 27 579
Maria Bogdanova Russia 9 271 1.4× 94 0.5× 90 0.5× 140 1.5× 27 0.5× 16 458
Valentina Galuppo Spain 7 174 0.9× 184 1.0× 47 0.3× 120 1.3× 40 0.7× 9 466

Countries citing papers authored by Г А Франк

Since Specialization
Citations

This map shows the geographic impact of Г А Франк's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Г А Франк with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Г А Франк more than expected).

Fields of papers citing papers by Г А Франк

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Г А Франк. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Г А Франк. The network helps show where Г А Франк may publish in the future.

Co-authorship network of co-authors of Г А Франк

This figure shows the co-authorship network connecting the top 25 collaborators of Г А Франк. A scholar is included among the top collaborators of Г А Франк based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Г А Франк. Г А Франк is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Вторушин, С. В., et al.. (2023). Assessment of HER2 status of carcinomas of various localizations. Russian Journal of Archive of Pathology. 85(6). 31–31. 1 indexed citations
2.
Завалишина, Л Э, et al.. (2022). Results of the work of the Russian Medical Academy of Continuous Professional Education Center for quality control of immunohistochemical studies for 2019—2021. Russian Journal of Archive of Pathology. 84(2). 72–72. 2 indexed citations
3.
Завалишина, Л Э, et al.. (2020). Immunohistochemical study of the MSI phenotype of urothelial bladder cancer. Russian Journal of Archive of Pathology. 82(1). 5–5. 1 indexed citations
4.
Завалишина, Л Э, et al.. (2019). Assessment of PD-L1 expression in patients with urothelial cancer with contraindications to platinum based therapy. Malignant tumours. 9(1). 10–15. 1 indexed citations
5.
Завалишина, Л Э, et al.. (2019). Updated 2018 ASCO/CAP recommendations on the definition of human epidermal growth factor receptor type 2 (HER2) in breast cancer. Russian Journal of Archive of Pathology. 81(6). 82–82. 1 indexed citations
6.
Andreeva, Yu Yu, et al.. (2019). Smooth muscle tumors of uncertain malignant potential. Russian Journal of Archive of Pathology. 81(3). 5–5. 1 indexed citations
7.
Франк, Г А, et al.. (2019). PD-L1 status in breast cancer. Russian Journal of Archive of Pathology. 81(2). 3–3. 3 indexed citations
8.
Франк, Г А, et al.. (2019). Study of the PD-L1 status in breast cancer, by using the SP142 monoclonal antibody, and the prospects for determining treatment policy. Russian Journal of Archive of Pathology. 81(5). 5–5. 1 indexed citations
9.
Andreeva, Yu Yu, et al.. (2017). A modern approach to the diagnosis and evaluation of regression after neoadjuvant therapy in breast cancer patients. Malignant tumours. 38–41. 1 indexed citations
10.
Франк, Г А, et al.. (2015). The role and assessment of morphological regression after neoadjuvant therapy in breast cancer patients. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Poddubnaya, I V, et al.. (2015). Heterogenety of stage I breast cancer: biological and prognostic value. Malignant tumours. 35–35. 3 indexed citations
12.
Andreeva, Yu Yu, et al.. (2015). Intravascular leiomyomatosis. Russian Journal of Archive of Pathology. 77(3). 51–51. 2 indexed citations
13.
Alekseev, B. Yа., et al.. (2014). THE RATE AND SITE OF LYMPH NODE METASTASES DURING RADICAL PROSTATECTOMY AND EXTENDED LYMPHADENECTOMY IN PATIENTS WITH PROSTATE CANCER. SHILAP Revista de lepidopterología. 2 indexed citations
14.
Alekseev, B. Yа., et al.. (2014). THE RATE AND SITE OF LYMPH NODE METASTASES DURING RADICAL PROSTATECTOMY AND EXTENDED LYMPHADENECTOMY IN PATIENTS WITH PROSTATE CANCER. Cancer Urology. 8(1). 77–81. 1 indexed citations
15.
Velde, Cornelis J.�H. van de, et al.. (2014). BIoLoGIcAL AND PRoGNoSTIc RoLE oF TuMoR SIZE (T 1a , T 1b , T 1c ) IN STAGE I BREAST cANcER (ExPERIENcE oF INTERNATIoNAL cooPERATIoN). 6. 1 indexed citations
16.
Sajet, Anita, Gerrit‐Jan Liefers, Esther Bastiaannet, et al.. (2012). Прогностическое значение возраста больных при раннем раке молочной железы. 1 indexed citations
17.
Франк, Г А, et al.. (2011). Neuroendocrine tumors of the lung. Russian Journal of Oncology. 16(4). 8–14. 3 indexed citations
18.
Соколов, В. В., et al.. (2010). Endobronkhial'naya khirurgiya i fotodinamicheskaya terapiya pri zlokachestvennykh opukholyakh trakhei i bronkhov. Russian Journal of Oncology. 15(3). 4–9.
19.
Франк, Г А, et al.. (2005). [Matrix metalloproteinases and their tissue inhibitors in basal cell and metatypical cancer of the skin].. PubMed. 67(3). 14–6. 1 indexed citations
20.
Afanasyeva, N. I., et al.. (1998). Minimally invasive and ex vivo diagnostics of breast cancer tissues by fiber optic evanescent wave Fourier transform IR(FEW-FTIR) spectroscopy.. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 3250. 140–147. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026